Upstream Technical Symposium
October 3, 2019 | Saint Julien en Genevois, France
Merck and Pierre Fabre CDMO invite you to the Upstream Technical Symposium which will take place at the Centre d'Immunologie Pierre Fabre (CIPF) in France on October 3, 2019.
During this one-day seminar you will:
Number of seats is limited and subject to availability. Attendance is free of charge.
Agenda*
| 8:45 - 9:15 | Welcome and presentation of the Pierre Fabre CDMO platform Cédric Borgne, Director, Biotechnology Unit, Pierre Fabre CDMO |
| 9:15 - 10:00 |
Cell line development: Reduce time to clinic and improve antibody productivity with
CHOZN® GS-/- cell line
Speaker TBC |
| 10:00 - 10:45 | New Applying orthogonal analytics to better understand molecule’s biological activity
Dr. Daniel Galbraith, Director of Strategy and Product Characterisation, focusing on the BioReliance® portfolio, Merck |
| 10:45 - 11:00 | Break |
| 11:00 - 11:30 |
New molecules to boost CHO productivity, simplify fed-batch processes and modulate critical
quality attributes Janine Caspari, Scientist, Advanced Cell Culture Technologies, Upstream R&D, |
| 11:30 – 12:15 | Scaling strategies with single-use bioreactors. Novel clarification strategies
Lénaïg, MSAT Upstream Biomanufacturing Engineer, Merck |
| 12:15 – 13:15 | Lunch |
| 13:15 – 14:00 | Facets of upstream processes intensification from cell banking to production in
bioreactors Habib Horry, Associate Director USP Integration Strategy, Merck |
| 14:00 – 14:30 | Roundtables
Establishing and applying critical quality attributes of the biological molecule during its development lifecycle - Alain Beck, Pierre Fabre CDMO Facets of seed train intensification - Sylvain Ribaud, Merck Specificity of management and control for raw materials used in biologics clinical batches - Sandrine Lauthier, Director, Quality Assurance, Pierre Fabre CDMO |
| 14:30 - 16:00 | Break and GMP Antibody/ADC Biotechnology Unit facility tour |
*Agenda subject to change. Attendance to the Upstream Technical Symposium is limited and available to pharma or biopharma manufacturers and academics only. The offer does not extend to any company that provides pharma or biopharma products or services. Merck and Pierre Fabre CDMO reserve the right to revoke or refuse participation at any time. The meeting is free of charge. Lunch and coffee breaks are provided compliments of Pierre Fabre CDMO. Hotel accommodations and travel costs are at the expense of the attendees.